MAJOR MEDICAL STUDIES LIST - CANNABIS TREATS CANCER
Major Medical Studies That Demonstrate Cannabis Can Treat Cancer
By now, there is little doubt that cannabis can treat cancer in the laboratory, in animal studies and there is also an abundance of patient testimonials to be found on social media, facebook, twitter, reddit, and you name it. Here is a list of the latest medical papers by leading institutions from around the world, reporting on precisely how cannabinoids, THC and CBD, the active ingredients of cannabis, kill the various kinds of cancer.
Brain Cancer
** MEDICAL CANNABIS STUDY ** A pilot clinical research study of delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
** MEDICAL CANNABIS STUDY ** Neuroprotection by delta9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
** MEDICAL CANNABIS STUDY ** Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in cancers
420EvaluationsOnline: Cancer patients often require large quantities of cannabis, 1 gram or more per day, or 5 grams of herb equivalent to reduce tumor size. Fortunately in California, the price is reduced by 25% (tax exemption) for medical marijuana patients. The process of getting a California medical cannabis card for 2018 and physician's recommendation takes only minutes online. Just fill out the questionnaire about your symptoms and conditions and your 420 evaluation will be completed shortly after you press send. 420Eol documents are accepted at dispensaries, delivery services and at other legal points of access in the State of California.
** MEDICAL CANNABIS STUDY ** Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
** MEDICAL CANNABIS STUDY ** Crosstalk between chemokine receptor CXCR4 and Phytocannabinoid receptor CB2 in modulating breast cancer growth and invasion.
** MEDICAL CANNABIS STUDY ** Phytocannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer tumor growth and metastasis.
** MEDICAL CANNABIS STUDY ** Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer tumor cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.
** MEDICAL CANNABIS STUDY ** The endogenous (body's own) cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2
** MEDICAL CANNABIS STUDY ** Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic Phytocannabinoid.
** MEDICAL CANNABIS STUDY ** Abstracts: Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic ** MEDICAL CANNABIS STUDY ** Lethality in Cancer
** MEDICAL CANNABIS STUDY ** January 4–7, 2017; San Diego, CA
** MEDICAL CANNABIS STUDY ** Abstracts: AACR International Conference: New Frontiers in Cancer Research
** MEDICAL CANNABIS STUDY ** January 18–22, 2017; Cape Town, South Africa
** MEDICAL CANNABIS STUDY ** Proceedings: AACR Annual Meeting 2017
** MEDICAL CANNABIS STUDY ** April 1–5, 2017; Washington, DC
** MEDICAL CANNABIS STUDY ** Abstracts: AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research
** MEDICAL CANNABIS STUDY ** April 23–25, 2017; San Diego, CA
** MEDICAL CANNABIS STUDY ** Abstracts: Second AACR Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies
** MEDICAL CANNABIS STUDY ** May 6–9, 2017; Boston, MA
** MEDICAL CANNABIS STUDY ** Abstracts: Advances in Sarcomas: From Basic Science to Clinical Translation
** MEDICAL CANNABIS STUDY ** May 16–19, 2017; Philadelphia, PA
** MEDICAL CANNABIS STUDY ** Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics
** MEDICAL CANNABIS STUDY ** October 26–30, 2017; Philadelphia, PA
** MEDICAL CANNABIS STUDY ** Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
** MEDICAL CANNABIS STUDY ** Expression of Phytocannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
** MEDICAL CANNABIS STUDY ** Phytocannabinoid Receptor-Mediated Apoptosis Induced by R+-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma
** MEDICAL CANNABIS STUDY ** Expression of Phytocannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
** MEDICAL CANNABIS STUDY ** The dual effects of delta9-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.
